Feasibility of tocilizumab in ICU patients with COVID-19.

Issa, Nahéma; Dumery, Margot; Guisset, Olivier; Mourissoux, Gaelle; Bonnet, Fabrice; Camou, Fabrice

Issa, Nahéma; Dumery, Margot; Guisset, Olivier; Mourissoux, Gaelle; Bonnet, Fabrice; Camou, Fabrice.

Issa N; Medical Intensive Care and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.
Dumery M; Medical Intensive Care and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.
Guisset O; Medical Intensive Care and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.
Mourissoux G; Medical Intensive Care and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.
Bonnet F; Internal medicine and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.
Camou F; Medical Intensive Care and Infectious Diseases Unit, Saint-Andre Hospital, Bordeaux, France.

J Med Virol ; 93(1): 46-47, 2021 01.

Article in English | MEDLINE | ID: covidwho-459151

Subject(s)

COVID-19 Drug Treatment; SARS-CoV-2; Antibodies, Monoclonal, Humanized; Cytokine Release Syndrome; Feasibility Studies; Humans; Intensive Care Units; Receptors, Interleukin-6

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26110

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google